Open AccessErythematous Papular Rash: A Dermatological Feature of COVID-19
Author(s) -
Catarina Gonçalves,
Nuno Reis Carreira,
Dúlio Teixeira Passos,
Ana Barbosa,
Ana Maria Baltazar,
Alexandra Wah,
A Abrantes,
Pedro Garrido,
Teresa Ferreira,
Marisa Teixeira Silva,
Lourdes Alvoeiro
Publication year - 2020
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2020_001768
Subject(s) - medicine , dermatology , livedo reticularis , rash , maculopapular rash , pityriasis rosea , disease , covid-19 , pathology , infectious disease (medical specialty)
COVID-19 is the clinical expression of the highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection. Most patients have mild symptoms, but a significant proportion have severe or critical disease, which can include cardiac injury, sepsis, acute kidney failure and respiratory failure. It is also worth highlighting the increasing number of reported COVID-19 cases with dermatological disease/manifestations. The cutaneous clinical spectrum is wide and includes maculopapular, urticarial, varicelliform and petechial rashes, pseudo perniosis, livedo reticularis, and pityriasis rosea-like, violaceous and pustular lesions. Until the physiological mechanism is fully understood, it is important to describe these manifestations, which could help identify a typical pattern. This report describes a cutaneous manifestation in a COVID-19 patient.